CIO Sells $1.3M in Stock as Shares Rally Over 70% and Q3 Revenue Soars 43.5%
On Dec. 29, Alignment Healthcare’s Chief Information Officer sold 69,541 shares for about $1.3 million at an average price of $18.74, representing 12.2% of his direct holdings and exceeding his typical 4.91% stake sales. The sale coincided with shares up 73% over the past year following Q3 revenue of $993.7 million, 43.5% growth year-over-year, membership up nearly 26% and $32.4 million in adjusted EBITDA, prompting raised full-year guidance across all major metrics.
1. Chief Information Officer Robert Scavo Executes $1.3 Million Sale
On December 29, Alignment Healthcare’s Chief Information Officer, Robert L. Scavo, sold 69,541 shares of directly held common stock for total consideration of approximately $1.3 million, as reported on an SEC Form 4. The sale price reflected a weighted average of $18.74 per share, and post-transaction, Scavo retains 503,014 shares valued at roughly $9.53 million. This single disposition represents 12.2 percent of his direct holdings, significantly above his recent median sale size of 4.91 percent, though below his largest-ever disposal of 100,863 shares in June 2025.
2. Chief Medical Officer Kim Hyong Reduces Stake by 3.5 Percent
On January 6, CMO Kim Hyong sold 16,506 shares at approximately $21.35 per share, following a December 29 sale of 12,694 shares at $18.74. These transactions generated proceeds of roughly $352,300 and $237,900, respectively, and reduced Hyong’s stake from 349,639 to 333,133 shares—a 3.50 percent decline. No options, derivatives or indirect holdings were involved in either sale; both were disclosed on Form 4 filings as directly held common stock.
3. Strong Operating Momentum in Third Quarter
In its most recent quarter, Alignment Healthcare reported revenue of $993.7 million, up 43.5 percent year-over-year, driven by a 26 percent increase in total membership. The company posted adjusted EBITDA of $32.4 million and raised full-year guidance across enrollment, revenue and profitability metrics. Over the trailing twelve months, revenue reached $3.64 billion, while net loss narrowed to $20.81 million, underscoring improving unit economics in its tech-enabled Medicare Advantage business.
4. Balance Sheet and Valuation Profile
As of the latest reporting period, Alignment Healthcare carried a debt-to-equity ratio of 2.04, indicating more than twice as much debt as equity on the balance sheet, but maintained a current ratio of 1.61, reflecting solid near-term liquidity. The company’s valuation multiples include a negative price-to-earnings ratio of –203.72 and a price-to-sales ratio of 1.17, while enterprise-value-to-sales stands at 1.09 and enterprise-value-to-operating-cash-flow at 21.88. These figures highlight a growth company investing for scale but still absorbing higher costs relative to earnings.